Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 34 filings·Updated 30 Sept 2026
Showing 10 of 34 filings.
30 Sept 20261 filing
AGM/EGMAGM

Coral Laboratories' 44th AGM approves all resolutions, reappoints directors, and ratifies cost auditor remuneration

AGM Details

  • Date and time: 29-09-2026, 12:30-12:39 PM.
  • Mode: Hybrid meeting with video conferencing facility.
  • Record date: 22-09-2026.
  • Shareholders on record: 4,007.
  • Attendance via video conferencing: 2 promoters, 18 public.
  • Scrutinizer: Raju Ananthanarayanan (SARK & Associates LLP).
  • Resolutions passed: 6.
  • Meeting duration: 9 minutes.

Key Resolutions

  • Adoption of standalone financial statements and reports — Ordinary — Passed.
  • Re-appointment of Mrs. Sushma Kadkade as Director liable to retire by rotation — Ordinary — Passed.
  • Re-appointment of Mr. Rajendra Singh Rana as Director liable to retire by rotation — Ordinary — Passed.
  • Ratification of remuneration of Cost Auditor for year 2026-27 — Ordinary — Passed.
  • Declaration of dividend on equity shares — Ordinary — Passed.
  • Remuneration to Mrs. Sushma Kadkade, Non-Executive Director — Special — Passed.

Dividend

  • Dividend on equity shares approved.

Director Changes

  • Re-appointments by rotation: Mrs. Sushma Kadkade and Rajendra Singh Rana.

Auditors & Remuneration

  • Cost Auditor remuneration ratified for year 2026-27.
Filed 11:30View Source
29 Sept 20261 filing
AGM/EGMAGM

Coral Laboratories' 44th AGM via VC approves final dividend, reappoints two directors, and ratifies cost auditor remuneration

AGM Details

  • Date/time/mode: 29 Sep 2026, 12:30–12:39 PM, via VC/OAVM.

Key Resolutions

  • Adoption of Audited Financial Statements, Directors' and Auditors' Reports for FY2025-26.
  • Final dividend declared on equity shares for FY2025-26.
  • Re-appointment of Mrs. Sushma Kadkade by rotation.
  • Re-appointment of Mr. Rajendrasinh Rana by rotation.
  • Ratification of remuneration of Cost Auditor for 2026-27.
  • Approval of remuneration to Mrs. Sushma Kadkade, Non-Executive Director.

Dividend

  • Final dividend declared on equity shares for FY2025-26; per-share amount not disclosed.

Auditor Appointments

  • Cost Auditor remuneration ratified for 2026-27.

Voting Results

  • Voting results to be announced within 48 hours and posted on company website and NSDL.
Filed 13:09View Source
25 Sept 20262 filings
Insider Trading / SASTClosure of Trading Window

Coral Laboratories Ltd trading window closed from October 1, 2026 till 48 (forty eight) hours after declaration of unaudited standalone financial results for the quarter and half year ending on September 30, 2026; the trading window shall open after 48 hours of declaration of the said results.

Coral Laboratories Ltd trading window closed from October 1, 2026 till 48 (forty eight) hours after declaration of unaudited standalone financial results for the quarter and half year ending on September 30, 2026; the trading window shall open after 48 hours of declaration of the said results.

Filed 15:10View Source
Board MeetingOutcome of Board Meeting

Board approves CRA-3 Cost Audit Report for FY 2025-26

Cost Audit Report approval

  • Approved Cost Audit Report CRA-3 for FY 2025-26.
Filed 15:00View Source
21 Sept 20261 filing
Board Meeting

Coral Laboratories Board to consider cost audit report for FY 2025-26 at Sep 25, 2026 meeting

Meeting Details

  • Board meeting scheduled for Friday, September 25, 2026; time and venue not disclosed.

Key Agenda Items

  • Consider and approve cost audit report for FY 2025-26.
  • Any other business with the permission of the chairman.
Filed 11:35View Source
5 Sept 20261 filing
Company UpdateNewspaper Publication

News paper Publication of dispatch of notice

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 14:28View Source
3 Sept 20261 filing
Company UpdateNewspaper Publication

Copy of News paper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 12:11View Source
14 Aug 20263 filings
AGM/EGMAGM

Coral Laboratories to hold 44th AGM on Sep 29, 2026 via VC/OAVM; notice to follow

AGM Details

  • 44th AGM scheduled for Sep 29, 2026 at 01:00 PM IST.
  • To be held via Video Conferencing / Other Audio Visual Means (VC/OAVM).
  • Board approved convening on Aug 14, 2026.
  • Notice and Annual Report to be shared in due course.
Filed 18:16View Source
Corp. ActionRecord Date

Coral Laboratories fixes record date for final dividend and book closure for AGM

Book Closure and Dividend Record Date

  • Record date for final dividend: 22 September 2026.
  • Book closure: 23 September 2026 to 29 September 2026 (inclusive) for AGM.
  • Purpose: AGM-related action with dividend entitlement.
Filed 18:06View Source
Board MeetingOutcome of Board Meeting

Coral Laboratories approves standalone unaudited Q1 2026-27 results; fixes AGM date and book-closure.

Key disclosures

  • Standalone unaudited quarterly results for quarter ended 30 June 2026 approved.
  • Draft Directors' Report and Secretarial Audit Report approved, with annexures.
  • 44th AGM fixed for 29 September 2026.
  • Notice of AGM and Annual Report to be shared in due course.
  • Book closure from 23 to 29 September 2026 (inclusive).
  • Cut-off date for AGM: 22 September 2026.
  • Scrutinizer for AGM appointed: M/s Sark & Associates LLP.
  • Independent Auditor's Review completed; no material misstatement identified.
Filed 17:57View Source
Showing 10 of 34 filings